Methandrostenolone (Dianabol) 10mg

Methandrostenolone 10mg (Dianabol) | NexorinPharma

Methandrostenolone 10mg is an oral anabolic steroid containing 10mg of Methandrostenolone per tablet. At NexorinPharma, we carry Methandrostenolone 10mg as part of our oral anabolic steroid inventory for customers in markets where Methandrostenolone is legally available.

Methandrostenolone is the active compound in this preparation, widely known under the brand name Dianabol. It is one of the most historically significant oral anabolic steroids ever developed and carries a well-documented presence in both clinical research and performance community discussions spanning several decades. Unlike many anabolic steroids discussed in performance communities, Methandrostenolone carries a documented history of clinical use and research that provides meaningful pharmacological context.

Like all oral anabolic-androgenic steroids, Methandrostenolone 10mg carries significant health and legal considerations. This page covers what Methandrostenolone is, how it works, and what health and legal considerations apply. It does not constitute medical advice. It does not recommend or encourage steroid use. It does not provide dosage, cycle, or stacking guidance of any kind.

Product Specifications

What Is Methandrostenolone

Methandrostenolone is a synthetic anabolic-androgenic steroid derived from testosterone. CIBA developed it in the late 1950s and introduced it to the US market under the brand name Dianabol in 1958. From the beginning, it was one of the first anabolic steroids specifically developed for performance enhancement alongside its clinical applications. It consequently became one of the most widely used and discussed oral anabolic steroids in history.

Structurally, Methandrostenolone is a modified form of testosterone. A methyl group at the 17-alpha position allows it to survive first-pass liver metabolism when taken orally. In addition, a double bond between carbon atoms 1 and 2 of the steroid structure reduces its androgenic activity relative to testosterone while preserving strong anabolic activity. These structural modifications produce an oral anabolic steroid with significant anabolic potency and meaningful estrogenic activity through aromatization.

The resulting pharmacological profile produces an anabolic rating of 90 to 210 and an androgenic rating of 40 to 60 relative to a testosterone baseline of 100. Strong anabolic activity combined with significant estrogenic conversion and notable liver toxicity consequently defines Methandrostenolone’s pharmacological profile.

How Methandrostenolone Works

Methandrostenolone is active when taken orally. The 17-alpha alkylation allows it to pass through the liver without complete breakdown, reaching systemic circulation in active form.

Androgen Receptor Binding

Methandrostenolone binds to androgen receptors throughout the body. Its androgenic rating of 40 to 60 is lower than testosterone’s baseline of 100, reflecting its reduced androgenic activity relative to its anabolic potency. As a result, androgen receptor activation in muscle tissue drives its anabolic effects while producing comparatively lower androgenic activity in androgen-sensitive tissues than testosterone-based compounds.

Nitrogen Retention

Methandrostenolone produces very strong positive nitrogen retention in muscle tissue. The body retains significantly more nitrogen than it excretes. Consequently, this produces a pronounced anabolic environment that strongly favors rapid muscle repair and growth. This mechanism is one of the most consistently referenced pharmacological characteristics of Methandrostenolone in both clinical and performance community discussions.

Protein Synthesis

Methandrostenolone accelerates protein synthesis in skeletal muscle tissue at a rate consistent with its high anabolic rating. Faster protein synthesis supports rapid muscle repair and growth following training. This mechanism is directly tied to its androgen receptor activity and contributes to the rapid mass accumulation observations consistently reported in performance community discussions about Methandrostenolone use.

Aromatization to Estrogen

Methandrostenolone converts to estrogen through the aromatase enzyme pathway. This aromatization produces significant estrogen elevation and drives estrogenic side effects including water retention, gynecomastia, and mood changes. As a result, estrogen management is a primary consideration with Methandrostenolone use. The degree of aromatization is meaningful and requires active management for anyone using this compound.

Glycogenolysis

Methandrostenolone enhances glycogenolysis, the breakdown of glycogen stored in muscle tissue into glucose for energy during exercise. This mechanism improves muscular energy availability during training and is one of the consistently documented pharmacological characteristics of Methandrostenolone. Furthermore, this glycogenolytic effect contributes to the strength and performance observations discussed in performance communities.

IGF-1 Stimulation

Methandrostenolone increases Insulin-like Growth Factor 1 production. IGF-1 plays a direct role in muscle repair, recovery, and anabolic activity throughout the body. This mechanism consequently contributes to the recovery-related observations consistently reported in performance community discussions about Methandrostenolone use.

About the 10mg Concentration

The 10mg per tablet concentration of Methandrostenolone represents the lower end of non-prescription market tablet formats for this compound. Understanding this context is relevant for anyone researching this specific product.

Comparison With Standard Clinical Formats

Historical pharmaceutical grade Dianabol tablets were available at 2.5mg and 5mg formats in US clinical settings before market withdrawal. The 10mg concentration consequently exceeds historical US pharmaceutical clinical tablet formats. However, 10mg tablets were produced in several international markets where Methandrostenolone maintained prescription availability longer than in the United States.

Comparison With Higher Concentration Non-Prescription Formats

Non-prescription Methandrostenolone is available at various concentrations in performance markets including 10mg, 20mg, 25mg, and 50mg tablet formats. The 10mg format represents the most conservative concentration available among standard non-prescription Methandrostenolone presentations. As a result, it provides more precise dose management than higher-concentration formats.

Non-Prescription Market Context

Methandrostenolone 10mg is produced for markets where Methandrostenolone is legally available outside of prescription channels. It does not carry the manufacturing oversight, regulatory scrutiny, or clinical documentation of pharmaceutical grade prescription products. Quality, purity, and concentration accuracy are consequently less verifiable than with regulated products.

Methandrostenolone Versus Other Oral Anabolic Steroids

Versus Oxymetholone (Anadrol)

Oxymetholone is a more potent oral anabolic steroid with a higher anabolic rating than Methandrostenolone. Both compounds produce estrogenic effects, though through different mechanisms. Oxymetholone produces estrogenic activity through direct estrogen receptor activation rather than conventional aromatization, while Methandrostenolone aromatizes directly to estrogen. Both are 17-alpha alkylated with significant liver toxicity. Oxymetholone consequently represents a more aggressive compound than Methandrostenolone across most pharmacological parameters.

Versus Oxandrolone (Anavar)

Oxandrolone is a non-aromatizing oral anabolic steroid with significantly milder liver toxicity than Methandrostenolone. Compared to Methandrostenolone, Oxandrolone produces no estrogenic conversion, lower liver stress, and a significantly more favorable overall side effect profile. These two compounds consequently occupy fundamentally different positions on the oral anabolic steroid potency and risk spectrum.

Versus Stanozolol (Winstrol)

Stanozolol is a non-aromatizing oral anabolic steroid with significant liver toxicity. Unlike Methandrostenolone, Stanozolol does not produce estrogenic effects through aromatization. Both carry 17-alpha alkylation-related liver toxicity. However, Methandrostenolone’s significant aromatization profile produces a fundamentally different estrogenic side effect consideration than Stanozolol.

Versus Turinabol

Turinabol is a non-aromatizing oral anabolic steroid structurally derived from Methandrostenolone with a chlorine atom added to prevent aromatization. This structural difference produces a compound with lower anabolic activity than Methandrostenolone but without the significant estrogenic side effects associated with aromatization. Turinabol consequently represents a milder non-estrogenic alternative to Methandrostenolone.

Versus Methenolone Acetate (Oral Primobolan)

Methenolone Acetate is a non-aromatizing oral anabolic steroid with very low liver toxicity due to its non-17-alpha alkylated structure. Methandrostenolone carries significantly higher anabolic activity than Methenolone Acetate but also carries significant aromatization and considerably more pronounced liver toxicity. These two compounds consequently represent fundamentally different pharmacological profiles across all relevant parameters.

Clinical Background

Methandrostenolone carries a documented clinical history that provides relevant context for its pharmacological profile.

Original Clinical Development

CIBA developed Methandrostenolone in the late 1950s with specific clinical applications including treatment of hypogonadism, osteoporosis, and muscle wasting conditions. It was FDA approved and commercially available in the United States under the Dianabol brand name from 1958. The FDA subsequently withdrew its approval in 1985 after CIBA discontinued marketing the drug, though it continued to be manufactured in other countries.

Muscle Wasting and Osteoporosis

Methandrostenolone was used clinically for the treatment of muscle wasting conditions and osteoporosis. Its potent anabolic effects on muscle tissue and bone provided clinical relevance for these indications. This clinical history provides a broader research base for understanding its pharmacological profile and documented anabolic effects in human subjects.

Research Context

The extensive clinical and observational research base accumulated across decades of Methandrostenolone use in both clinical and performance contexts provides one of the most comprehensive pharmacological documentation bases of any oral anabolic steroid. This research consequently informs the well-characterized side effect profile and pharmacological understanding of the compound.

Side Effects and Health Risks

Methandrostenolone 10mg carries a well-documented side effect profile based on extensive clinical research and decades of observational data. These risks are significant and cannot be minimized in any responsible discussion of this compound.

Liver Toxicity

Liver toxicity is the most serious health concern associated with Methandrostenolone use. As a 17-alpha alkylated oral steroid, the alkylation that allows oral bioavailability places significant and direct stress on liver tissue. Clinical research and case reports document elevated liver enzymes and in cases of prolonged or high-dose use, more serious hepatic complications. Liver monitoring through regular blood work is therefore essential for anyone using this compound.

Estrogenic Effects

Methandrostenolone converts significantly to estrogen through the aromatase enzyme pathway. Elevated estrogen levels consequently produce water retention, gynecomastia, and mood changes. Aromatase inhibitors are commonly referenced in performance communities for managing estrogen conversion with Methandrostenolone use. The degree of aromatization makes estrogen management one of the primary health considerations with this compound.

Cardiovascular Effects

Methandrostenolone produces significant adverse lipid profile changes. HDL cholesterol drops sharply while LDL cholesterol increases substantially. These lipid changes carry serious long-term cardiovascular health implications. Furthermore, water retention from estrogenic activity contributes to elevated blood pressure. Regular cardiovascular monitoring is therefore essential for anyone using this compound.

Hormonal Suppression

Methandrostenolone suppresses the hypothalamic-pituitary-gonadal axis and the body’s natural testosterone production. Post-use hormonal disruption can persist for months. In some cases, it results in long-term or permanent hypogonadism requiring ongoing medical treatment.

Androgenic Effects

Despite its relatively low androgenic rating, Methandrostenolone still produces androgenic side effects in susceptible individuals. These include accelerated hair loss in genetically predisposed individuals and acne. In women, virilization risks are serious considerations even at lower doses.

Blood Pressure

Water retention from estrogenic activity and adverse lipid changes both contribute to blood pressure increases with Methandrostenolone use. Regular blood pressure monitoring is consequently a relevant health consideration for anyone using this compound.

Psychological Effects

Anabolic steroid use carries documented associations with mood changes and irritability. These considerations consequently apply to Methandrostenolone use at any concentration. Regular psychological monitoring is therefore relevant for anyone using this compound over extended periods.

Legal and Regulatory Status

Methandrostenolone carries Schedule III controlled substance status in the United States under the Controlled Substances Act. The FDA withdrew its approval in 1985 after CIBA discontinued marketing. Possession without a valid prescription is consequently a federal offense.

In the United Kingdom, Methandrostenolone falls under Class C of the Misuse of Drugs Act. Supply is illegal.

The World Anti-Doping Agency bans Methandrostenolone alongside all major athletic governing bodies. As a result, it appears on prohibited substance lists across Olympic sports, professional athletics, and competitive bodybuilding organizations that conduct testing.

You are responsible for confirming the legal status of Methandrostenolone in your specific jurisdiction before purchasing from NexorinPharma.

Frequently Asked Questions

Is Methandrostenolone 10mg Available at NexorinPharma

Yes. NexorinPharma carries Methandrostenolone 10mg for customers in markets where Methandrostenolone is legally available. Visit nexorinpharma.com to check current availability and pricing.

What Is the Half-Life of Methandrostenolone

Methandrostenolone produces a half-life of approximately 3 to 6 hours. As a result, its relatively short half-life requires regular daily administration to maintain stable plasma concentrations throughout the day.

Does Methandrostenolone Aromatize

Yes. Methandrostenolone converts significantly to estrogen through the aromatase enzyme pathway. Consequently, estrogenic side effects including water retention and gynecomastia are primary health considerations with this compound.

How Does the 10mg Concentration Compare to Other Formats

The 10mg format represents the most conservative concentration available among standard non-prescription Methandrostenolone presentations. Higher concentration formats of 20mg, 25mg, and 50mg are available in non-prescription markets. The 10mg format consequently provides more precise dose management than higher-concentration alternatives.

What Are the Most Serious Health Risks

Liver toxicity from 17-alpha alkylation is the most serious health concern with Methandrostenolone. In addition, cardiovascular effects from significant lipid dysregulation and water retention, estrogenic effects including gynecomastia and water retention, and hormonal suppression complete the primary risk profile. Medical supervision and regular blood work monitoring are therefore essential for anyone using this compound.

Is Methandrostenolone 10mg Legal to Purchase

Methandrostenolone carries Schedule III controlled substance status in the United States. Legal status varies by jurisdiction. You are consequently responsible for confirming the legal status in your jurisdiction before purchasing from NexorinPharma.

What to Consider Before Purchasing Methandrostenolone 10mg

Methandrostenolone has one of the most extensively documented pharmacological profiles of any oral anabolic steroid. Decades of clinical research, observational data, and performance community discussion provide a substantial body of information about its effects and risk profile. That research base consequently applies to its pharmacological profile regardless of the specific manufacturer or concentration format.

Non-prescription Methandrostenolone preparations do not carry the manufacturing oversight of pharmaceutical grade products. The 10mg concentration represents the most conservative non-prescription format available, providing more precise dose management than higher-concentration alternatives. However, Methandrostenolone’s significant aromatization, liver toxicity, and cardiovascular risk profile remain relevant at any concentration.

Methandrostenolone carries documented liver, cardiovascular, estrogenic, hormonal, androgenic, and psychological health risks. These risks require medical supervision to manage responsibly. Regular blood work monitoring including liver enzymes, lipid panels, estrogen levels, and hormone levels is therefore essential for anyone using this compound.

For customers in markets where Methandrostenolone is legally available, visit nexorinpharma.com to check current Methandrostenolone 10mg availability, pricing, and stock levels.